Fan, F., Yoo, H. J., Stock, S., Wang, L., Liu, Y., Schubert, M., . . . Sellner, L. (2021). Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients. International journal of cancer, 148(2), . https://doi.org/10.1002/ijc.33212
Chicago-Zitierstil (17. Ausg.)Fan, Fuli, et al. "Ibrutinib for Improved Chimeric Antigen Receptor T-cell Production for Chronic Lymphocytic Leukemia Patients." International Journal of Cancer 148, no. 2 (2021). https://doi.org/10.1002/ijc.33212.
MLA-Zitierstil (9. Ausg.)Fan, Fuli, et al. "Ibrutinib for Improved Chimeric Antigen Receptor T-cell Production for Chronic Lymphocytic Leukemia Patients." International Journal of Cancer, vol. 148, no. 2, 2021, https://doi.org/10.1002/ijc.33212.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.